Saki Nakagawa

Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study

Minoru Miyashita, Hironobu Sasano, Kentaro Tamaki et al. · Breast Cancer Research · 2015 · 250 citations · Full text

Medicine, Immunology, Oncology +17

Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy

Minoru Miyashita, Hironobu Sasano, Kentaro Tamaki et al. · Breast Cancer Research and Treatment · 2014 · 97 citations

Medicine, Immunology, Oncology +11

Effects of the sodium‐glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan

Ken Ohara, Takahiro Masuda, Takuya Murakami et al. · Nephrology · 2018 · 81 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease

Ken Ohara, Takahiro Masuda, Masato Morinari et al. · Diabetology & Metabolic Syndrome · 2020 · 65 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy

Fouzia Guestini, Katsuhiko Ono, Minoru Miyashita et al. · Breast Cancer Research and Treatment · 2018 · 42 citations

Medicine, Cancer Biology, Oncology +16